Where Does Mereo BioPharma Group plc - ADR (MREO) Stock Fall in the Biotechnology Field After It Has Risen 0.96% This Week?

Mereo BioPharma Group plc - ADR (MREO) is near the top in its industry group according to InvestorsObserver. MREO gets an overall rating of 95. That means it scores higher than 95 percent of stocks. Mereo BioPharma Group plc - ADR gets a 100 rank in the Biotechnology industry. Biotechnology is number 48 out of 148 industries.

MREO has an Overall Score of 95. Find out what this means to you and get the rest of the rankings on MREO!

See Full MREO Report

What do These Ratings Mean?

Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. InvestorsObserver allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 95 would rank higher than 95 percent of all stocks. These scores are not only easy to understand, but it is easy to compare stocks to each other. You can find the best stock in an industry, or look for the sector that has the highest average score. The overall score is a combination of technical and fundamental factors that serves as a good starting point when analyzing a stock. Traders and investors with different goals may have different goals and will want to consider other factors than just the headline number before making any investment decisions.

What's Happening With Mereo BioPharma Group plc - ADR Stock Today?

Mereo BioPharma Group plc - ADR (MREO) stock is up 10.79% while the S&P 500 has fallen -0.07% as of 2:17 PM on Thursday, Nov 30. MREO has gained $0.21 from the previous closing price of $1.90 on volume of 913,793 shares. Over the past year the S&P 500 has risen 11.45% while MREO has gained 167.09%. MREO lost -$0.36 per share the over the last 12 months. Click Here to get the full Stock Report for Mereo BioPharma Group plc - ADR stock.